As requested by Elizlow. Listed since 5 May 2004 on SGX Mainboard, Asiapharm Group Ltd is engaged in the research, development, production, distribution and sale of pharmaceutical drugs with major operations in China.
From chart, next support at .675 and .65 , rsi is weak at the m
oment and may consolidate for awhile between the .675-.65 level before staging a rebound. Target at .72 followed by .78. Right now, the moving averages would serve as a resistance and capping any upward thrust at the .72 region.
From chart, next support at .675 and .65 , rsi is weak at the m
oment and may consolidate for awhile between the .675-.65 level before staging a rebound. Target at .72 followed by .78. Right now, the moving averages would serve as a resistance and capping any upward thrust at the .72 region.
No comments:
Post a Comment